Delivery Order SPE2DB20D3103-SPE2DB25FP3W7

Award Date 7/3/25
Potential Completion Date 7/7/25
Potential Value $1.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,287.68, is for the delivery of 4,567,956,474 units of the prescription medication lisdexamfetamine 40 mg capsules. The contract is a firm fixed-price, non-set-aside arrangement with an ultimate completion date of April 18, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 10 mg Lisdexamfetamine capsules. The firm fixed-price contract has a ceiling value of $1,152.39 and a completion date of July 7, 2025. The contract is not set aside and is an open competition award. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Lisdexamfetamine 40 mg capsules. The contract has a ceiling value of $1,719.90 and a period of performance through June 23, 2025. It is a firm-fixed-price contract, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 100-count bottles of the medication Lisdexamfetamine 40 mg capsules, with a ceiling value of $1,859.10 and a period of performance ending on May 6, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. AmerisourceBergen Drug Corp holds a larger...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of lisdexamfetamine 10 mg capsules, a prescription medication. The contract has a ceiling value of $1,057.51 and runs through March 3, 2025. The contract is a firm fixed-price delivery order and was not set aside for any specific business type. AmerisourceBergen holds a larger...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,647.20, is for the delivery of 90 units of the prescription drug lisdexamfetamine 50 mg capsules. The contract is a firm fixed-price delivery order, with a performance period extending through July 7, 2025. AmerisourceBergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop...
This is a $1,160.12 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 100 units of the prescription medication lisdexamfetamine 40 mg capsules. It has an ultimate completion date of July 2, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,033,529 units of the prescription medication lisdexamfetamine 30 mg capsules. The contract is a firm fixed-price, non-set-aside delivery order with a ceiling value of $1,976.17 and a performance period through April 28, 2025. Amerisourcebergen Drug Corp also holds a larger...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of lisdexamfetamine 10 mg capsules. The contract has a firm fixed-price, non-set-aside designation and a ceiling value of $3,341.32. The period of performance extends through June 24, 2025. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00,...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to supply 100-count bottles of the prescription medication lisdexamfetamine 50 mg capsules. The fixed-price contract has a ceiling value of $2,652.70 and a completion date of June 18, 2025. The contract is not set aside for any specific business size or socioeconomic category. AmerisourceBergen Drug Corp holds a substantial Indefinite...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB25FP3W7
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 90-count capsules of the medication lisdexamfetamine 40 mg, with a total ceiling value of $1,913.69. The contract has a performance period ending on July 7, 2025 and is a firm fixed-price arrangement. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This delivery order contract is not designated as a set-aside. The contract supports federal medical procurement needs, particularly for military and veteran healthcare systems.

Generated 10/2/25, 10:48 AM